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Pathological gastro-oesophageal reflux (GOR) is primarily a
disorder of gastro-intestinal (foregut) motility characterised by
episodes of inappropriate relaxation of the lower oesophageal
sphincter.'-' However, the disorder may involve a complex mix
of foregut dysfunction including impaired oesophageal
clearance, gastro-oesophageal reflux, antropyloric inco-
ordination and delay in gastric emptying. Individually or
together, depending on the pattern and severity, these may
'have a wide spectrum of adverse effects.
ormal infants often regurgitate recently ingested gastric
contents during the first hour after feeding.4 It remains difficult
to delineate the boundary between physiological reflux,
causing uncomplicated positing, and pathological reflux
(gastro-oesophageal reflux disease - GORD), requiring active
therapy to prevent morbidity and mortality. Physicians are
often called upon to decide on the need for appropriate
investigations and management in these children. Because of
the great propensity for physiological reflux to resolve
spontaneously within the first 10 - 12 months of life, physicians
have customarily been cautious in evaluating and treating such
infants in the absence of complications.
Signs and symptoms of pathological GOR include persistent
vomiting with failure to thrive; objective evidence of reflux
oesophagitis; reflux leading to nasopharyngeal irritation and
recurrent otitis media; or reflux-associated respiratory disease.
The latter may vary in presentation from an asthma-like
syndrome to recurrent migratory pneumonia, chronic
obstructive airways disease and 'death attacks' resulting from
reflux-associated laryngeal spasm and vagal stimulation.s In
addition acid reflux may stimulate reactive airways via
neurological pathways, thus exacerbating the asthma diathesis."
Ontogenetically the gastro-intestinal tract appears at
approximately the 4th week of gestation as a hollow tubular
structure, and at 13 weeks the oesophageal muscular layer,
myenteric plexus and regulatory peptides are present.
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Swallowing has been documented to commence in the fetus
between 11 and 17 weeks' gestation, and the lower oesophageal
sphincter (LOS)'s high-pressure zone has been identified from
33 weeks.' Despite the oesophagus being structurally and
functionally intact from this early age, synchronous peristaltic
activity is present in less than 60% of newborns, and
approximately 40% of the peristaltic waves are incomplete or
retrograde.
Pathological reflux is predominantly linked to inappropriate
transient relaxation of the LOS, or relaxation that occurs in the
absence of a peristaltic sequence in the body of the oesophagus.
These findings have contributed to a better understanding of
the pathophysiology and complexity of gastro-oesophageal
disease.'-'
The European Society of Paediatric Gastroenterology and
utrition (ESPGAN) published guidelines in 1993 for the
treatment of GOR in infants (Table I)! We believe these
guidelines require scrutiny, as in our experience some are
impractical and may be inappropriate. Particularly
controversial are the roles of positional therapy, feed
thickeners, antacids, and the medical treatment of persistent
occult gastro-oesophageal reflux in older children. The 30°
prone reversed Trendelenburg position may not be indicated in
children under 6 months of age. Feed thickeners such as cereals
or rice are rapidly hydrolysed in the stomach and sodium
alginate antacids may cause sodium overload in premature
babies (approximately 8 mmol sodium/day at a dose of 1/4
sachet Infant Gaviscon per feed). Experience with H,-blockers
is very limited in infants, and these drugs may cause rebound
nocturnal acid secretion. IO-" Persistence with ineffective long-
term medical therapy may unnecessarily place the infant at
risk.
Clinically paediatric GOR can be divided into two broad
categories, cases with predisposing disease and those without.
Table I. Schematic therapeutic approach to GOR
Phase 1
lA. Position: prone reversed (head elevated)
Trendelenburg position (30")
18. Milk-thickening agents
le. Dietary recommendations: increased frequency, small
volume
ID. Alginic acid (± antacid)
Phase 2
Prokinetics: dsapride (if symptoms are resistant to cisapride:
domperidone, metocloprarnide, alizapride, bethanechol).
Phase 3
3A. H,-blockers: drnetidine, ranitidine, farnotidine
3B. 'Experimental' treatment sucralphate, omeprazole,
misoprostol
Phase 4
Surgery (Nissan fundoplication, ThaI fundoplication,
anterior gastropexy of Boerema, etc.)
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The latter category comprises two types. The 'infantile' refluxer
becomes symptomatic in the first few months of life, \Nith
spontaneous resolution occurring in most cases. 13 If therapy is
started early, 90% will have resolved by 10 - 12 months of age.'
The second type is the so-called 'childhood' refluxer, in whom
either infantile reflux persists, or the condition reappears when
the child is older. The intensity of symptoms fluctuates in the
latter group, but in at least 50% of cases the condition does not
resolve and will require intermittent ongoing or definitive
therapy.'
The first category comprises GOR with predisposing or
associated disease, neurological impairment being the most
important. Other conditions occurring with equal frequency are
genetic and chromosomal disorders; intrathoracic gastric
herniation; reflux after oesophageal atresia repair, usually with
gastrostomy; reflux following caustic stricture of the
oesophagus; and established lung disease.
The most difficult of these patients, both to assess and to
treat, are those with respiratory disease. In some the respiratory
disease comes first, reflux exacerbating and perpetuating the
lung disease; in others it is the reflux, with recurrent aspiration
or stimulation via neural pathways, that precipitates and
maintains the respiratory disease. It is difficult to prove a
diagnosis of reflux-induced asthma, although pH studies often
show a close correlation between GOR with coughing and
acute episodes of wheezing in asthmatic children. I" Treatment
of GOR in asthmatic children with prokinetic agents has been
shown to improve the incidence and severity of the disease."
The prevalence of pathological reflux among low-birth-
weight infants is 3 - 10%, with symptoms of irritability, apnoea,
bradycardia, vomiting and deterioration of bronchopulmonary
disease.' The overall prevalence among infants under 1 year of
age is difficult to establish. In the USA approximately 7% of
infants are brought to a medical practitioner for GOR; of these
80% will resolve on minimal therapy and without
investigations, 12% will be investigated and treated
successfully with conservative measures, and 8% will undergo
antireflux surgery.'·13 The prevalence of pathological reflux in
children over 1 year of age is unknown. Each year some 80
children are referred to the surgical department at Red Cross
War Memorial Children's Hospital for consideration for
surgical management.
DIAGNOSTIC STUDIES
In the work-Up of suspected GOR, it is important to avoid
inappropriate investigations. The diagnostic evaluation must
include a complete history and physical examination. Orenstein
et al. l • have developed a questionnaire for parents with a
positive predictive value of 100%, th~reby improving the
efficiency and reliability of history taking.
A barium meal is a prerequisite in the symptomatic child for
the anatomical assessment of the foregut and identification of
possible associated structural abnormalities and disorders of
peristaltic function which may cause vomiting. Twenty-four hour
pH monitoring is only indicated in patients with nonspecific or
intermittent symptoms to confirm the presence of GOR and to
quantitate its severity. Monitoring of pH may also be helpful in
the evaluation of the effect of posture and specific treatment on
reflux.s The correlation between oesophageal pH monitoring
ana respiratory disease may be improved by the use of a dual
pH recording probe.in the upper and lower oesophagus as well
as by monitoring reflux episodes during sleep periods. 17."
Oesophageal manometry is difficult to perform in infants and
reference values have not been standardised.7 However, a lower
oesophageal sphincter pressure of less than 10 mmHg usually
correlates with significant reflux. Manometry can be combined
with motility studies using a continuously perfused lumen
catheter attached to a multichannel recorder. About one-third
of all patients with GOR have some oesophageal dysmotility.19
Technetium scintigraphy provides a good functional
assessment of physiological oesophageal motor function and
transit time, as well as gastric emptying.'" Quantification of
reflux episodes and documentation of pulmonary aspiration
are of less value as scanning is of short duration, being
immediately postprandial and performed in an infant
restrained in the supine position.'" Ultrasonography is a new and
non-invasive method to determine the presence of reflux and
associated hiatus hernia under physiological circumstances. It
has been validated against existing methods, and may play a
major role in assessing pathological reflux immediately after
meals, and elucidating symptoms such as irritability, unusual
posturing, chronic cough, wheezing and chronic respiratory
tract infection!]
Endoscopy with biopsy is most valuable for the diagnosis of
organic oesophageal disease. Visual evidence of oesophagitis is
present in the minority (about 30%) of children with GOR, but
its absence does not exclude pathological reflux, which may
only be detected histologically.S.22 Barrett's oesophagus can only
be diagnosed on specific histological findings, and although
rare it may be important in the assessment of children with
prolonged reflux disease, especially those with neurological




Treatment of GOR is directed at the various identified
pathophysiological components. The majority of infants can be
successfully treated conservatively while awaiting
improvement as spontaneous maturation of the physiological
antireflux mechanisms occurs. As immaturity of foregut
function predisposes premature infants to pathological reflux
disease, treatment is more effective in this group of patients.s
The vast majority will outgrow the condition, especially if
aggressive medical therapy is initiated early, good compliance
is assured and adequate nutrition is maintained.
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Neurologically impaired children have a considerably higher
incidence of COR due to a predominant supine position,
scoliosis, diaphragmatic flaccidity, abdominal spasticity,
swallowing difficulties, general body weakness, and muscular
inca-ordination.2• Among these children therapy and
compliance remain difficult, and should be adapted to
individual requirements. Antireflux surgery may be combined
with a feeding gastrostomy.
Reassurance of parents forms an integral component of
management. Babies who are thriving and whose parents'
main complaint is soiling of clothes from regurgitant vomits
('spitting') require no investigation other than a full medical
history and examination. Modification of the feed preparations
and the volume per feed, as well as of the handling of the baby
postprandially, may improve many of the symptoms. Parents
should also be asked to avoid tight clothing, feeding just before
bedtime, and high-osmolality feeds." Symptoms which should
prompt more extensive investigation include inconsolable
crying and irritability, feeding or sleeping difficulties, and
persistent vomiting.'3 However, there must be a clear
understanding that conservative measures should not be
continued over a protracted period without first excluding
anatomical abnormalities by radiological investigation with a
contrast swallow and meal.
POSTURE
The prone elevated position (anti-Trendelenburg) at 30°
inclination has been shown to reduce critical components of
COR. The frequency and duration of reflux episodes and
associated pulmonary aspiration are decreased, energy
expenditure is diminished and gastric emptying is improved.2h
Positional therapy aimed at maintaining an erect posture is
difficult to maintain, especially in infants who tend to assume a
slumped or supine posture. The flat-prone position does not
improve oesophageal clearance as assessed on pH-metry and
has been associated with an increased risk of sudden infant
death syndrome (SIDS).21 The therapeutic effect of varying
degrees of the anti-Trendelenburg position - 5°,10° or 20°-
or the right lateral prone position has not been evaluated.
Despite these observations the prone 30° head-up position is
recommended for a child with severe reflux in the absence of
any previous life-threatening respiratory episodes (apnoea,
bradycardia, aspiration), or in older infants (> 6 months, where
the SIDS risk is decreasedZ1) who are not responding to other
therapeutic procedures. The left lateral position is an
alternative to the prone position in young infants.28 Appropriate
positional therapy can be further directed by analysis of the pH
study, where wide differences in incidence and severity of
reflux may be documented in different positions in a single
patient.29
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DIETARY MEASURES
Feed thickeners have been shown to improve sleep and may
provide a 'feeling of well-being' in a significant number of
infants, as well as reducing the number and volume of reflux
episodes, although the results are unpredictable.5.30 However,
they fail to improve oesophageal acid clearance.30 Feeds of a
larger volume or a higher osmolality may increase the rate of
LOS phasic relaxation, which is important in the pathogenesis
ofCOR.2•
A commonly used feed thickener is one tablespoon (15 rnl) of
dry rice cereal added to each 25 ml of formula. This adds
additional calories, decreases vomiting and crying time and
increases sleep time during the postprandial period.' However,
it delays gastric emptying and is difficult to use in breast-fed
babies.' Constipation, a common side-effect, is best treated with
magnesium-eontaining antacids. Carob seed flower with
calcium lactate (Nestargel, 1 g/l00 rnl feed) and sodium
alginate (Gaviscon, 1 - 2 g/120 - 240 rnl feed) may also be
utilised as feed thickeners, although their efficacy appears to be
inconsistent.31..32 These agents are expensive and may be a
significant financial burden on the parents. Cornflour (Maizena
5 - 10 g/200 rnl feed) as an alternative feed thickener has been
shown to be effective in a pilot study at our hospital, is cheap
and is in our opinion the first choice.33
A feeding regimen of small frequent feeds may not provide .
adequate nutrition, especially to the hungry and agitated child,
and may interfere with sleeping patterns and other social
activities. During sleep, the LOS pressure usually increases and
transient lower oesophageal sphincter relaxation decreases.'
However, oesophageal acid clearance is reduced by a factor of
5 - 6 and salivary flow decreases from approximately 150 rnl/h
to 1 rnl/h resulting in the sleeping child losing the ability to
neutralise and clear refluxed acid.' In our experience
compliance with a frequent-feeding regimen is poor and the
benefits are questionable, especially during the first year of
rapid growth. It is imperative to maintain the nutritional
requirements of the infant.
PROKINETIC AGENTS
Pharmacological agents are used in conjunction with other
conservative measures once reflux disease has been
documented by special investigations. These agents collectively
improve oesophageal peristalsis, increase the LOS pressure and
promote gastric emptying. Four prokinetic agents have been
used for infant COR (bethanecol, domperidone,
metocloprarnide and cisapride) and work either by blocking
dopamine receptors or by potentiating the effect of
acetylcholine.29
The cholinergic action of bethanecol increases LOS pressure
and oesophageal motor function, but systemic parasympathetic
activity limits its implication as a first-line drug. Domperidone
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(Motilium), a dopamine receptor antagonist, reduces the
frequency of reflux but has no beneficial effect on acid
clearance and is not commonly used.29 Metodopramide
(Maxolon), an antidoparninergic and cholinomimetic drug, is
effective in reflux disease but psychotrophic, extrapyramidal
and dystonic side-effects, which are idiosyncratic, limit its long-
term use in children.).; The narrow therapeutic margin may
result in a considerable number of infants being irritable and
somnolent on a dosage as low as 0.4 mg/kg/d, and it is
therefore not recommended for infants younger than 1 year of
age.29
Cisapride (Prepulsid) has specific pharmacological activities
directed at those factors implicated in the pathogenesis of
GOR. It is the only prokinetic agent with documented
improvement, in pH meter studies, in children with GOR.29.35 It
has been safe and effective in our experience and we believe
should be the first-line prokinetic agent for GOR Optimal
effects are seen when cisapride is combined with dietary and
postural methods. It has minimal side-effects, viz. colic and
transient diarrhoea, but may take up to 1 week to exert its full
effect.29 ew pharmacokinetic data in premature infants have
revealed that plasma concentrations of cisapride, even when
the drug is given at the prescribed dosage, are extremely
variable and unpredictable. Cisapride may reach levels that put
these premature infants at risk of QT prolongation, which may
be associated with serious cardiac arrhythmias. In this patient
population electrolyte disturbances such as hypokalaemia
should be corrected before the administration of cisapride. The
concomitant use of other drugs metabolised via the P450
enzyme system (ketoconazole, itraconazole, miconazole,
troleandomycin, fluconazole, erythromycin, clarithromycin,
nefazodone and ritonavir) may result in elevated plasma levels
of cisapride.36 The recommended oral dose is 0.2 mg/kg given
6 - 8 hourly, 20 minutes before a feed. 35.36
ANTACIDS
Antacids, H,-receptor antagonists and proton pump inhibitors
can be used both to reduce gastric acidity and for the treatment
of oesophagitis. They do not influence the primary cause of
reflux disease in infants, but may improve oesophagitis, reduce
incompetence of the LOS and pyloric spasm, and improve the
oesophageal dysmotility associated with acid reflux.
Magnesium- or aluminium-eontaining antacids at a dose of
1 ml/kg/d in 4 divided doses may be useful in neutralising
gastric acid. Side-effects from overdose may rarely occur,
especially in low-birth-weight infants. Similarly, the benefit of
alginate antacid preparations in improving GOR is debatable,37
and these drugs can increase the sodium content of the feed to
an undesirable degree, especially in rremature infants.
Beneficial results were observed in our own observations with
Gaviscon and Nestargel.
Acid secretion-inhibiting agents such as the H,-receptor
antagonists and proton pump inhibitors are currently the
antacid therapies of choice.38.J9 They are effective in healing
mucosal lesions. Dosing schedules for infants have not been
determined and these drugs are therefore used empirically.
Omeprazole at a dose of 40 mg/1.73 m' body surface area per
day or 0.7 mg/kg/d as a divided twice-daily dose improved
symptoms, healed oesophagitis, and reduced intragastric
acidity.38-W For effective suppression of gastric acidity high-dose
ranitidine (20 mg/kg/d) could be used as an alternative.38
However, omeprazole has been shown to be more effective
than ranitidine, with improved symptomatic relief and rapid
healing of ulcerative oesophagitis.38 The tendency for
recurrence of symptoms in up to 60% of children after
withdrawal of these drugs indicates the need for long-term
maintenance therapy.39 The implications of the long-term use of
these drugs on growing children are unknown and concern
about the negative side-effects of hypo-acidity and
hypergastrinaemia (30%) have been raised.39 Their use in
infants should therefore be restricted to severe or refractory
oesophagitis, and for a defined time period. Titration of the
omeprazole dosage against repeated 24-hour intragastric pH
metry could limit excessive administration.
NASOJEJUNAL TUBE FEEDING
Duodenal or jejunal feeding with a fine-bore nasal tube has
been proposed as an alternative to surgery. It has been used in
premature and full-term infants, where age-related resolution is
anticipated. It is also useful for improving nutritional and
respiratory status prior to surgery in children with
uncontrollable symptoms, severe pulmonary complications
from aspiration, persistent vomiting and failure to thrive. If this
course of therapy is employed, it is important that antireflux
therapy be continued together with the addition of mycostatin
to prevent fungal infection.
FI A CIAL IMPLICATIO S
The financial implications of an extended course of medical
therapy should not be underestimated. The cost of therapy for
a 10 kg child on cisapride, omeprazole and antacid is
approximately R650 p~ month at 1997 prices.
SURGERY
The role of surgery for GOR in infancy is more clearly defined
than in adults. Surgery offers a highly effective cure for a ImI
problem which, if left untreated, may cause long-term
morbidity and even mortality. There is no justification for
persisting with ineffective medical therapy if the condition may
result in chronic illness, multiple hospitalisations, ongoing
pulmonary disease and stunted growth.
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In cases of proven CORD indications for surgical
intervention are failure of adequate medical therapy or poor
compliance; persistent failure to thrive; recurrent aspiration
syndrome; apnoeic spells or near-death attacks; ulcerative
oesophagitis!Barrett's oesophagus; oesophageal stricture;
anatomical abnormality, e.g. rolling hiatus hernia and
neurological impairment with poor feeding, vomiting or
rumination.'"
In children with chronic respiratory tract infections and
concomitant COR it remains very difficult to prove a cause-
and-effect relationship. Likewise, it is imperative to exclude
laryngopharyngeal inca-ordination leading to laryngeal
incompetence and aspiration. Common causes are post-
herpetic dysfunction, cerebral palsy and anatomical
abnormalities, e.g. laryngeal cleft. Clearly, surgery in these
situations is inappropriate.
Surgical correction should include four main elements -
mobilisation and maintenance of 2 - 3 cm of intra-abdominal
oesophagus; posterior crural repair; re-establishment of the
oesophagogastric angle of His; and an effective antireflux
barrier. Some have strongly advocated a fifth component,
namely a pyloroplasty or gastropyloroplasty, in cases with
proven delayed gastric emptying. Claimed advantages are a
lower incidence of recurrence and wrap disruption, particularly
in children with a seizure disorder. IS However, we have shown
improved gastric emptying in most cases after fundoplication
without disruption of the pyloric sphincter." Theoretical
disadvantages of pyloroplasty!pyloromyotomy may be a
lifelong predisposition to bile reflux, although one study
demonstrated minimal bile acid reflux and no change in
intragastric pH at 1- and 11!z-year follow-up evaluation.U
A short floppy (i.e. loose) issen fundoplication is the
operation performed most frequently, although several other
effective operations have been described. A variation of the
issen is the Toupet, a partial posterior fundoplication over
± 2700 of the oesophageal circumference." The fundus of the
stomach is secured posteriorly to the hiatal crura and anteriorly
to the anterolateral oesophagus on each side." Claimed
advantages over the Nissen are a lower incidence of
complications, particularly dysphagia, gas bloat and para-
oesophageal hernia.'" The procedure may be of particular
benefit in infants with poor oesophageal peristalsis; however,
there are no prospective studies confirming this advantage.
Another operation is an oblique 1800 partial anterior
fundoplication (Boix Ochoa), which has been shown to be
effective in preventing COR with a low incidence of
postoperative side-effects such as a gasbloat, dumping and
diarrhoea.'" This operation is similar to the Watson procedure
in adults and is effective in up to 95% of cases."" Early failure of
the antireflux procedure has been seen in neurologically
impaired and very malnourished children, with para-
oesophageal herniation of the fundus occurring in
approximately 10% of cases, usually as a late phenomenon.
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When this does occur, it causes dysphagia, is often associated
with recurrence of COR and requires revision surgery.
Discharge from hospital after these operations should be
possible within 72 - 96 hours. Although these operations are
highly effective in preventing COR, the underlying respiratory
problem in patients with asthma-like syndrome might persist
because of primary pulmonary disease, prior damage from
aspiration or ongoing aspiration due to cricopharyngeal inco-
ordination. Reoperation may be required in up to 10% of cases,
mainly because of wrap breakdown and!or hiatal hernia
formation.
LAPAROSCOPIC FUNDOPLICATION
Over the past 5 years there has been an explosion of activity in
laparoscopic and minimally invasive surgery:IS Laparoscopic
fundoplication has appeal in children over 12 months of age, as
visibility is excellent and in experienced hands the same
technical steps are followed as in open surgery. Although there
is undoubtedly a 'learning curve', equivalent results with less
postoperative morbidity have been achieved·'
CO CLUSIO S
In infants with suspected COR, clinical evaluation and selective
investigations will identify those with pathological reflux
requiring intensive medical treatment. Infants with typical
uncomplicated symptoms of reflux should be treated without
prior investigations. However, persistent symptoms in any
child require a contrast swallow and meal to exclude
anatomical abnormalities in the upper gastro-intestinal tract.
The natural history of spontaneous improvement in infants and
young children and the success of medical therapy should
militate against early surgery. However, with life-threatening
reflux disease, or with well-defined indications, a surgical
antireflux procedure offers a safe treatment option with
satisfactory long-term outcome.
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